頁籤選單縮合
| 題 名 | 臺灣疫苗不良事件通報系統(VAERS)現況=Current Status of Taiwan's Vaccine Adverse Event Reporting System (VAERS) |
|---|---|
| 作 者 | 黃建賢; 張藏能; | 書刊名 | 內科學誌 |
| 卷 期 | 36:6 2025.12[民114.12] |
| 頁 次 | 頁392-396 |
| 分類號 | 418.293 |
| 關鍵詞 | 疫苗安全監測; 疫苗猶豫; 主動監測; Vaccine safety monitoring; VAERS; Vaccine adverse event reporting system; Vaccine hesitancy; Active monitoring; |
| 語 文 | 中文(Chinese) |
| DOI | 10.6314/JIMT.202512_36(6).06 |
| 中文摘要 | 疫苗不良事件通報系統(Vaccine Adverse Event Reporting System, VAERS)是美國疾病 管制署與食品藥物管理局共同建立的被動監測系統,旨在偵測疫苗相關不良事件、識別潛 在風險並評估疫苗安全性。台灣亦建立類似通報流程,由衛福部、台灣疾病管制署(Centers for disease control, CDC)及衛生福利部食品藥物管理署(Taiwan Food and Drug Administration, TFDA)共同運作,以維持疫苗安全監測與資訊透明化。在目前的監測中,流感疫苗與 COVID-19疫苗的監測資料均顯示安全性良好,嚴重不良事件罕見且無死亡通報。VAERS雖 具全國性優勢,但仍可能受媒體或社會因素影響其通報率,因此需輔以主動監測系統以提升 通報準確度。以台灣的疫苗不良事件通報系統經驗證明,結合多層級專家審查、即時通報與 公開數據,有助於增進民眾對疫苗施打的信任並降低疫苗猶豫。 |
| 英文摘要 | The Vaccine Adverse Event Reporting System (VAERS) is a passive surveillance program jointly managed by the U.S. CDC and FDA to detect, analyze, and evaluate potential adverse events following immunization. Taiwan has developed a similar reporting and review mechanism coordinated by the Ministry of Health, CDC, and TFDA to ensure vaccine safety and data transparency. Monitoring data for both the recombinant quadrivalent influenza vaccine (RIV4) and COVID-19 vaccines have demonstrated strong safety profiles with no vaccine-related deaths reported. While VAERS provides a nationwide coverage advantage, reporting bias may occur due to media or social influences; hence, active surveillance systems are needed to complement passive monitoring. Taiwan’s experience highlights that integrating multi-level expert review, timely reporting, and open data sharing can enhance public trust and reduce vaccine hesitancy. |
本系統中英文摘要資訊取自各篇刊載內容。